These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6624980)

  • 21. L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS
    Br J Psychiatry; 1985 Jul; 147():16-22. PubMed ID: 3933601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated tricyclic antidepressant plasma concentrations associated with fluoxetine: two case reports.
    Michals M; Stanley DA; Crismon ML; Barrow NE
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):466-7. PubMed ID: 2136405
    [No Abstract]   [Full Text] [Related]  

  • 24. Synergistic action of alprazolam with tranylcypromine in drug-resistant atypical depression with panic attacks.
    Ries RK; Wittkowsky AK
    Biol Psychiatry; 1986 May; 21(5-6):522-6. PubMed ID: 3697440
    [No Abstract]   [Full Text] [Related]  

  • 25. Lack of desipramine toxicity with citalopram.
    Ashton AK
    J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
    [No Abstract]   [Full Text] [Related]  

  • 26. The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial.
    Razani J; White KL; White J; Simpson G; Sloane RB; Rebal R; Palmer R
    Arch Gen Psychiatry; 1983 Jun; 40(6):657-61. PubMed ID: 6342565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAR*D level IV methodology.
    Wingo AP; Ghaemi SN
    Am J Psychiatry; 2007 Apr; 164(4):681; author reply 681. PubMed ID: 17403987
    [No Abstract]   [Full Text] [Related]  

  • 29. Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trial.
    White K; Razani J; Cadow B; Gelfand R; Palmer R; Simpson G; Sloane RB
    Psychopharmacology (Berl); 1984; 82(3):258-62. PubMed ID: 6425910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological responsiveness of winter depression.
    Dilsaver SC; Del Medico VJ; Quadri A; Jaeckle S
    Psychopharmacol Bull; 1990; 26(3):303-9. PubMed ID: 2125735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peaked "T" waves with tranylcypromine (parnate) overdose.
    Quill TE
    Int J Psychiatry Med; 1981-1982; 11(2):155-60. PubMed ID: 7263132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of molindone and tranylcypromine in the treatment of refractory depression.
    Small JG; Kellams JJ; Dennis JL; Milstein V
    J Clin Pharmacol; 1981; 21(8-9):351-8. PubMed ID: 7276229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium or desipramine augmentation of fluoxetine treatment.
    Nelson JC; Price LH
    Am J Psychiatry; 1995 Oct; 152(10):1538-9. PubMed ID: 7573606
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of tranylcypromine (parnate) on eyelid conditioning and paired associate learning in depressed patients.
    Weckowicz TE; Nutter R; Gibbs JT
    Pavlov J Biol Sci; 1974; 9(2):122-3. PubMed ID: 4220365
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA; Mesones HL; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prior antidepressant treatment does not have an impact on response to desipramine treatment in major depression.
    Young LT; Cooke RG; Levitt AJ; Joffe RT
    Biol Psychiatry; 1995 Sep; 38(6):410-2. PubMed ID: 8547462
    [No Abstract]   [Full Text] [Related]  

  • 39. Electrocardiographic effects of tranylcypromine vs. amitriptyline.
    White K; O'Leary J; Razani J; Rebal R; Palmer R
    J Clin Psychiatry; 1983 Mar; 44(3):91-3. PubMed ID: 6833194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind study of tranylcypromine treatment of major anergic depression.
    Himmelhoch JM; Fuchs CZ; Symons BJ
    J Nerv Ment Dis; 1982 Oct; 170(10):628-34. PubMed ID: 7050302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.